We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00669669
Recruitment Status : Active, not recruiting
First Posted : April 30, 2008
Last Update Posted : January 9, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 24, 2018
  Estimated Study Completion Date : December 31, 2027